Transforming growth factor-β produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin
Authors:
- Shery LeSLShery Le
Open Access
- 1 September 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 13 (9) , 1147-1154
Abstract
The induction of epidermal immunity depends on activation of local dendritic cells (DC), Langerhans cells (LC), to migrate from the skin to local lymph nodes and mature into potent immunostimulatory cells. We have previously shown that progressor skin tumors, which evade immunological destruction, prevent contact sensitizer-induced LC migration from the skin to draining lymph nodes. In contrast, regressor tumors, which evoke protective immunity, did not inhibit DC mobilization. In this study we utilized the skin explant model to determine the factors produced by skin tumors which regulate LC migration from the skin. Supernatants from two progressor squamous cell carcinoma lines both inhibited LC migration, whereas supernatants from two regressor squamous cell carcinoma lines both enhanced LC mobilization. Transforming growth factor (TGF)-β1 inhibited, while IL-10 enhanced, LC migration from cultured skin. Both reduced the ability of LC to mature into potent allostimulators. Antibody neutralization identified that TGF-β1 produced by the progressor tumor was responsible for inhibition of LC migration, while IL-10 produced by the regressor tumor enhanced LC mobilization. Thus these studies show that skin tumors influence DC mobilization from tumors by production of cytokines, and that TGF-β1 is one factor produced by tumors which can immobilize LC and keep them in an immature form. This is likely to be an important mechanism of tumor escape from the immune system as progressor tumors inhibited, while regressor tumors enhanced DC mobilization.Keywords
This publication has 31 references indexed in Scilit:
- Effect of interleukin‐10 on dendritic cell maturation and functionEuropean Journal of Immunology, 1997
- A Role for Endogenous Transforming Growth Factor β1 in Langerhans Cell Biology: The Skin of Transforming Growth Factor β1 Null Mice Is Devoid of Epidermal Langerhans CellsJournal of Experimental Medicine, 1996
- All-trans retinoic acid induces functional maturation of epidermal Langerhans cells and protects their accessory function from ultraviolet radiationExperimental Dermatology, 1994
- Stimulation of Langerhans Cell Migration by Tumor Necrosis Factor α (TNF-α)Journal of Investigative Dermatology, 1992
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Migration and maturation of Langerhans cells in skin transplants and explants.Journal of Experimental Medicine, 1990
- Functional Dichotomy between Langerhans Cells that Present Antigen to Naive and to Memory/Effector T LymphocytesImmunological Reviews, 1990
- Immunosuppressive Effects of Transforming Growth Factor β: Inhibition of the Induction of Ia Antigen on Langerhans Cells by Cytokines and the Contact Hypersensitivity ResponseJournal of Investigative Dermatology, 1990
- Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.Journal of Experimental Medicine, 1988
- Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.Journal of Experimental Medicine, 1987